Calzetta相关文献与解析，生知库 | 链接生命科学的每一步

Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside

长效毒蕈碱受体拮抗剂治疗难治性重症哮喘：从基础研究到临床应用，聚焦炎症的叙述性综述

Calzetta, Luigino; Manzetti, Gian Marco; Pistocchini, Elena; Lauro, Renato Federico; Gholamalishahi, Shima; Cazzola, Mario; Rogliani, Paola

哮喘

炎症

炎症/感染

信号转导

Immunology/Inflammation

发表日期：2026

文献求助收藏

Redox signaling in chronic airway diseases: pathogenic mechanisms and therapeutic implications

慢性气道疾病中的氧化还原信号传导：致病机制和治疗意义

期刊:Frontiers in Physiology

影响因子:3.4

doi:10.3389/fphys.2026.1734890

Cazzola, Mario; Rogliani, Paola; Calzetta, Luigino; van Haren, Frank M P; Page, Clive; Matera, Maria Gabriella

信号转导

发表日期：2026

文献求助收藏

Centripetal Axonal Transport as a Gateway to the CNS for Veterinary Antiparasitics: Bypassing the Blood-Brain Barrier, Clinical Impact in Vulnerable Age Groups, and the Potential Facilitating Role of PFAS

向心性轴突运输作为兽用抗寄生虫药物进入中枢神经系统的途径：绕过血脑屏障、对易感年龄组的临床影响以及 PFAS 的潜在促进作用。

期刊:Journal of Toxicology

影响因子:3

doi:10.1155/jt/1785323

Britti, Domenico; Marabelli, Romano; Calzetta, Luigino

Dose of Inhaled Corticosteroids and Cardiovascular Disease in Asthma: An Unexpected Misstep?

吸入性皮质类固醇剂量与哮喘患者心血管疾病：意想不到的失误？

期刊:American Journal of Respiratory and Critical Care Medicine

影响因子:19.4

doi:10.1164/rccm.202409-1788LE

Rogliani, Paola; Calzetta, Luigino

Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I Error

慢性阻塞性肺疾病中的心血管事件：过度依赖 ETHOS 数据库获取临床证据存在 I 类错误风险

期刊:American Journal of Respiratory and Critical Care Medicine

影响因子:19.4

doi:10.1164/rccm.202410-1922LE

Calzetta, Luigino; Rogliani, Paola

慢性阻塞性肺疾病

发表日期：2025

文献求助收藏

Ensifentrine Plus a Long-Acting Muscarinic Antagonist in COPD: A Trifunctional Dual Bronchodilation Perspective

恩西芬特林联合长效毒蕈碱受体拮抗剂治疗慢性阻塞性肺疾病：三功能双重支气管扩张视角

期刊:Drugs

影响因子:14.4

doi:10.1007/s40265-025-02213-w

Cazzola, Mario; Page, Clive P; Calzetta, Luigino; Martinez, Fernando J; Rogliani, Paola; Matera, Maria Gabriella

PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis

PI3K抑制剂作为治疗伴有动脉粥样硬化的慢性阻塞性肺疾病的潜在治疗药物

期刊:Drugs

影响因子:14.4

doi:10.1007/s40265-025-02179-9

Cazzola, Mario; Page, Clive; Rogliani, Paola; Calzetta, Luigino; Matera, Maria Gabriella

Endogenous p21 levels protect genomic stability by suppressing both excess and restrained nascent DNA syntheses.

内源性 p21 水平通过抑制过量和受限的新生 DNA 合成来保护基因组稳定性。

期刊:Science Advances

影响因子:12.5

doi:10.1126/sciadv.adw4618

Calzetta NicolÃ¡s L, Mansilla Sabrina F, Ahlers Candelaria Mares, Bertolin Agostina P, Caimi Lilen I, Arbilla SofÃa Venerus, Zeng Jingkun, WiesmÃ¼ller Lisa, Gottifredi Vanesa

发表日期：2025

文献求助收藏

Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene

根据疾病严重程度分析气道阻塞性黏液栓对慢性阻塞性肺疾病（COPD）患者死亡率的影响：COPDGene数据的子集分析

期刊:International Journal of Chronic Obstructive Pulmonary Disease

影响因子:3.1

doi:10.2147/COPD.S504065

Rogliani, Paola; Calzetta, Luigino

Mucus as a Treatable Trait in Chronic Airway Diseases

慢性气道疾病中黏液分泌过多是一种可治疗的特征

Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside

长效毒蕈碱受体拮抗剂治疗难治性重症哮喘：从基础研究到临床应用，聚焦炎症的叙述性综述

Redox signaling in chronic airway diseases: pathogenic mechanisms and therapeutic implications

慢性气道疾病中的氧化还原信号传导：致病机制和治疗意义

Centripetal Axonal Transport as a Gateway to the CNS for Veterinary Antiparasitics: Bypassing the Blood-Brain Barrier, Clinical Impact in Vulnerable Age Groups, and the Potential Facilitating Role of PFAS

向心性轴突运输作为兽用抗寄生虫药物进入中枢神经系统的途径：绕过血脑屏障、对易感年龄组的临床影响以及 PFAS 的潜在促进作用。

Dose of Inhaled Corticosteroids and Cardiovascular Disease in Asthma: An Unexpected Misstep?

吸入性皮质类固醇剂量与哮喘患者心血管疾病：意想不到的失误？

Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I Error

慢性阻塞性肺疾病中的心血管事件：过度依赖 ETHOS 数据库获取临床证据存在 I 类错误风险

Ensifentrine Plus a Long-Acting Muscarinic Antagonist in COPD: A Trifunctional Dual Bronchodilation Perspective

恩西芬特林联合长效毒蕈碱受体拮抗剂治疗慢性阻塞性肺疾病：三功能双重支气管扩张视角

PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis

PI3K抑制剂作为治疗伴有动脉粥样硬化的慢性阻塞性肺疾病的潜在治疗药物

Endogenous p21 levels protect genomic stability by suppressing both excess and restrained nascent DNA syntheses.

内源性 p21 水平通过抑制过量和受限的新生 DNA 合成来保护基因组稳定性。

Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene

根据疾病严重程度分析气道阻塞性黏液栓对慢性阻塞性肺疾病（COPD）患者死亡率的影响：COPDGene数据的子集分析